Steve Allen, MD

Steve Allen, MD, is CEO of Nationwide Children’s Hospital, a position he has held since 2006. Nationwide Children’s treats children from around the world as an elite, destination, pediatric teaching hospital and research institution. He leads an organization that has defined a new model for delivering state of the art care and generating new cures in an environment of unsurpassed quality. Nationwide Children’s shares its knowledge by teaching the next generation of providers and developing innovative community outreach programs to address critical healthcare needs. All this is firmly wrapped in the hospital’s 130-year mission to provide every child with the finest medical care regardless of their families’ ability to pay.


Dr. Allen is gratified to lead such a purpose-driven organization. Nationwide Children’s success is fueled by an environment of continuous improvement. He derives remarkable insights from asking all levels of staff and families for their ideas on how the organization can do even better. While there are successful healthcare executives who come from a broad background, his perspective gained from the practice of medicine not only influences how he prioritizes the work, but also how he leads.

His passion for population health and wellness drives participation in legislative advocacy at the state and national level. This focus is critical to advancing children’s healthcare. Dr. Allen was appointed Chair of the Children’s Hospital Association (CHA) 2016 Board of Trustees.

Carlos E. Alvarez, PhD

Carlos E. Alvarez, PhD, is a principal investigator in The Research Institute at Nationwide Children’s Hospital and associate professor of Pediatrics at The Ohio State University College of Medicine. His lab’s biomedical research program is focused on two areas: dog and human genetics, and signal transduction. His studies have been funded by National Institutes of Health, Department of Defense, Canine Health Foundation and Morris Animal Foundation.

Anthony Audino, MD

Dr. Audino is a pediatric oncologist in Hematology/Oncology & BMT at Nationwide Children’s Hospital. His clinical and research interests include adolescent and young adult oncology, specifically solid tumors such as sarcoma and lymphoma. He has piloted, with grant support, a year-long program for AYA outreach education.

Mary Bates, PhD

Mary a freelance science writer and blogger based in Boston. Her favorite topics include biology, psychology, neuroscience, ecology, and animal behavior. She has a BA in Biology-Psychology with a minor in English from Skidmore College in Saratoga Springs, NY, and a PhD from Brown University, where she researched bat echolocation and bullfrog chorusing.

Gina Bericchia

Gina is a senior media relations strategist at Nationwide Children’s Hospital with a background in health care public relations. She previously worked at The Ohio State University Wexner Medical Center and is a graduate of Otterbein College.

Elise Berlan, MD, MPH

Dr. Berlan is a physician in the Section of Adolescent Medicine at Nationwide Childcare’s Hospital and associate professor of Pediatrics at The Ohio State University College of Medicine.  She is a researcher, educator, clinician and advocate for young women’s reproductive health. As founder and director of the BC4Teens/Young Women’s Contraception Program at Nationwide Children’s, she leads the hospital’s diverse efforts in teen pregnancy prevention. Dr. Berlan is also an active participant in local efforts in public health to reduce infant mortality.

Michael T. Brady, MD

Michael T. Brady, MD, is associate medical director at Nationwide Children’s Hospital, co-medical director for Patient Safety, a member of the hospital’s Division of Infectious Diseases and a Professor of Pediatrics at The Ohio State University College of Medicine. An infectious disease specialist for more than three decades, Dr. Brady began focusing on the emerging HIV epidemic in the mid-1980s and its implications for infants, children and adolescents. He created the country’s first family-centered pediatric HIV program at Nationwide Children’s in 1987. While still involved with the HIV program, his interests in recent years have included promoting immunization in children, reducing healthcare associated infections and providing guidance on emerging infections.

Dr. Brady served as physician-in-chief at Nationwide Children’s from 2005 to 2013 and chair of the Department of Pediatrics at OSU’s College of Medicine from 2006 to 2013. Under his leadership, OSU’s Pediatrics faculty nearly doubled in size. Dr. Brady also oversaw the development of Physician Direct Connect at Nationwide Children’s, a service that puts community pediatricians in nearly immediate contact with specialists for consultations. He is a long-time member of Nationwide Children’s Graduate Medical Education Committee, influencing the training of the next generation of physicians.

At the national level, Dr. Brady has served as chair of the American Academy of Pediatrics’ Committee on Infectious Diseases. He is currently the associate editor of Red Book, the comprehensive infectious disease reference from the AAP. He is also a member of the editorial panel for Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations from the NIH, CDC, HIV Medicine Association, PIDS and AAP. Other activities have involved global immunization advocacy, ongoing education of pediatricians across the country and service on task forces handling issues ranging from circumcision to meningococcal vaccines.

Timothy Cripe, MD, PhD

Dr. Cripe is chief of the Division of Hematology, Oncology and Blood and Marrow Transplantation at Nationwide Children’s Hospital. His clinical interests include gene and viral therapies for solid tumors in children, including brain tumors, neuroblastoma and bone and soft tissue sarcomas. Dr. Cripe’s current research focuses on developing and testing new therapies for pediatric solid tumors and translating those findings into clinical studies. He was among the first in the country to launch clinical trials of attenuated oncolytic viruses in children.

Kelly Kelleher, MD, MPH

Dr. Kelleher is a pediatrician whose research interests focus on accessibility, effectiveness and quality of health care services for children and their families, especially those affected by mental disorders, substance abuse or violence. He has a longstanding interest in formal outcomes research for mental health and substance abuse services. Dr. Kelleher is director of the Center for Innovation in Pediatric Practice and vice president of Health Services Research at The Research Institute at Nationwide Children’s Hospital. Dr. Kelleher is also professor in the Department of Pediatrics of The Ohio State University College of Medicine.

Tiasha Letostak, PhD

Tiasha is the senior strategist for Clinical & Research Communications at Nationwide Children’s Hospital. She provides assistance to investigators in The Research Institute and clinician-scientists at Nationwide Children’s for internal and external communication of clinical studies, peer-reviewed journal articles, grant awards and research news. She is also the editor-in-chief for Research Now, Nationwide Children’s monthly, all-employee e-newsletter for research, as well as a writer for Pediatrics Nationwide.

Brianne Moore

Brianne is interning as a science writer and editor for Clinical & Research Communications at Nationwide Children’s Hospital. She contributes to a variety of publications, including Pediatrics Nationwide and PediatricsOnline.

Jeb Phillips

Jeb is a senior writer and editor for Clinical & Research Communications at Nationwide Children’s Hospital. He contributes feature stories and research news to PediatricsOnline, the hospital’s electronic newsletter for physicians and other health care providers, and to Pediatrics Nationwide. He has served as a communications specialist at the Center for Injury Research and Policy at The Research Institute and came to Nationwide Children’s after 14-year career as daily newspaper reporter, most recently at The Columbus Dispatch.

Abbie Roth

Abbie is a science writer and editor focused on the communication of life science and medicine to diverse audiences. She is the editor of Pediatrics Nationwide and and a science writer for Clinical & Research Communication at Nationwide Children’s Hospital, contributing to a variety of publications. 

David Stukus, MD

Dr. Stukus is director of the Complex Asthma Clinic and a physician in the Section of Allergy/Immunology at Nationwide Children’s Hospital. He is also assistant professor of Pediatrics at The Ohio State University College of Medicine. His clinical and research interests focus on asthma and food allergies, especially improving education and adherence for patients and families. As part of his research, Dr. Stukus has created novel technology and educational tools using mobile health apps to improve the care of patients, for which he was recognized with the Nationwide Children’s Hospital Department of Pediatrics Junior Faculty Award for Innovation in November 2013. Dr. Stukus has been an active member of the medical advisory team for Kids with Food Allergies since 2009 and was elected to the Board of Directors for the Asthma and Allergy Foundation of America in 2014.

Elizabeth Varga, MS, LGC

Ms. Varga is a licensed genetic counselor in the Division of Hematology/Oncology/ Bone Marrow Transplant. Ms. Varga has 12 years of experience as a genetic counselor and has specialized in pediatric Hematology/Oncology for the past 5 years. She currently provides clinical genetic counseling and participates in research related to genetics of blood and cancer.

Susan Vear, MD

Dr. Vear is the co-director of the Program for Personalized Medicine and Pharmacogenomics in Hematology/Oncology/Blood and Bone Marrow Transplant at Nationwide Children’s Hospital and assistant professor at The Ohio State University College of Medicine. Her research interests include chemotherapy toxicities and pharmacogenomics. Clinically, she sees oncology patients with a focus on leukemia and cancer predisposition syndromes.

Pedro Weisleder, MD, PhD

Dr. Weisleder is an attending pediatric neurologist at Nationwide Children’s. He is professor of Clinical Pediatrics and director of the Pediatric Neurology Residency Program at The Ohio State University College of Medicine. Dr. Weisleder serves as director of the Center for Pediatric Bioethics at Nationwide Children’s Hospital. He is also co-chair of the Nationwide Children’s Integrated Ethics Committee.  Dr. Weisleder’s research interests include medical ethics and the interactions between medicine and the law. Dr. Weisleder has edited two books “Current Topics in Pediatric Epilepsy” and the “Manual of Pediatric Neurology.”

Nicholas Yeager, MD

Dr. Yeager is the director of the AYA Program at Nationwide Children’s. His clinical interests include bone tumors, soft tissue sarcomas and malignancy in AYA patients. He is also director of the pediatric Hematology/Oncology fellowship program and is involved in the Orthopedic Oncology Clinic.